Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Avatrombopag in Healthy Japanese and White Subjects
NCT02039076Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd. Primary endpoint: Pharmacokinetic profiles of avatrombopag up to 23 Weeks. Started Dec 2013; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02039076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039076.